AcouSort AB (ACOU) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.260x

Based on the latest financial reports, AcouSort AB (ACOU) has a cash flow conversion efficiency ratio of -0.260x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.86 Million ≈ $-522.69K USD) by net assets (Skr18.65 Million ≈ $2.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AcouSort AB defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

AcouSort AB - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how AcouSort AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

AcouSort AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AcouSort AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
RS Public Company Limited
BK:RS
-0.051x
Nvni Group Limited Ordinary Shares
NASDAQ:NVNI
0.049x
Alice QUEEN Ltd
AU:AQX
5.144x
Metalsgrove Mining Ltd
AU:MGA
-0.095x
Dynaciate Group Bhd
KLSE:5178
0.016x
Cahayaputra Asa Keramik Tbk PT
JK:CAKK
0.138x
ESSA Pharma Inc
NASDAQ:EPIX
-0.039x
Viking Mines Ltd
AU:VKA
-0.290x

Annual Cash Flow Conversion Efficiency for AcouSort AB (2013–2024)

The table below shows the annual cash flow conversion efficiency of AcouSort AB from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see ACOU market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr8.46 Million
≈ $910.75K
Skr-18.81 Million
≈ $-2.02 Million
-2.222x -69.95%
2023-12-31 Skr24.14 Million
≈ $2.60 Million
Skr-31.56 Million
≈ $-3.40 Million
-1.308x -763.33%
2022-12-31 Skr20.11 Million
≈ $2.16 Million
Skr3.96 Million
≈ $426.70K
0.197x +159.62%
2021-12-31 Skr33.02 Million
≈ $3.55 Million
Skr-10.92 Million
≈ $-1.17 Million
-0.331x +54.92%
2020-12-31 Skr9.59 Million
≈ $1.03 Million
Skr-7.04 Million
≈ $-757.08K
-0.733x +55.87%
2019-12-31 Skr5.92 Million
≈ $637.30K
Skr-9.84 Million
≈ $-1.06 Million
-1.662x -250.06%
2018-12-31 Skr15.58 Million
≈ $1.68 Million
Skr-7.40 Million
≈ $-796.04K
-0.475x +78.37%
2017-12-31 Skr3.88 Million
≈ $417.87K
Skr-8.53 Million
≈ $-917.43K
-2.195x -10113.03%
2016-12-31 Skr9.96 Million
≈ $1.07 Million
Skr-214.00K
≈ $-23.03K
-0.021x +99.78%
2015-12-31 Skr78.63K
≈ $8.46K
Skr-757.00K
≈ $-81.47K
-9.627x +57.84%
2014-12-31 Skr376.48K
≈ $40.52K
Skr-8.60 Million
≈ $-925.17K
-22.835x -89.13%
2013-12-31 Skr249.47K
≈ $26.85K
Skr-3.01 Million
≈ $-324.14K
-12.074x --

About AcouSort AB

ST:ACOU Sweden Biotechnology
Market Cap
$9.52 Million
Skr88.47 Million SEK
Market Cap Rank
#27158 Global
#593 in Sweden
Share Price
Skr4.18
Change (1 day)
-1.42%
52-Week Range
Skr2.13 - Skr4.99
All Time High
Skr31.61
About

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC … Read more